Oyster Point Pharma, Inc.

Historical 13F Holders

Symbol
OYST
CUSIP
69242L106
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 2 1.00 $11.00
2024 Q4 2 1.00 $11.00
2024 Q3 2 1.00 $11.00
2024 Q2 2 1.00 $11.00
2024 Q1 2 1.00 $11.00
2023 Q4 2 1.00 $11.00
2023 Q3 2 1.00 $11.00
2023 Q2 2 1.00 $11.00
2023 Q1 2 1.00 $11.00
2022 Q4 58 17.0 M $189 M
2022 Q3 63 20.0 M $113 M
2022 Q2 61 20.2 M $87.5 M
2022 Q1 72 21.1 M $246 M
2021 Q4 88 20.8 M $379 M
2021 Q3 70 17.8 M $211 M
2021 Q2 58 18.5 M $318 M
2021 Q1 61 18.4 M $336 M
2020 Q4 60 17.6 M $331 M
2020 Q3 66 18.1 M $383 M
2020 Q2 74 18.0 M $520 M
2020 Q1 45 13.3 M $465 M
2019 Q4 43 13.6 M $332 M